Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes where either the eyes are not capable of producing sufficient tears to maintain lubrication or the when produced, they evaporate too quickly. The condition can lead to various difficulties in the daily life of a person, such as reading for an extended period of time or using a computer. The condition can decrease the tolerance of a person in a dry environment such as air present inside an airplane.
Dry eye syndrome is gaining prominence due to the changing lifestyles, consumption of specified medicines, and increased rate of diseases. Autoimmune diseases, genetic factors, environmental conditions, and routine practices such as extended usage of contact lenses and prolonged computer usage also cause dry eye syndrome.
The dry eye syndrome drugs market is moderately populated owing to the presence of few key vendors competing intensely with smaller vendors. Vendors in the dry eye medication market compete based on the long-term efficacy of the drugs with minimum side effects. Dry eye syndrome drug manufacturers cater extensively to hospitals and pharmacies.
In 2019, the market size of Dry Eye Syndrome is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dry Eye Syndrome.
This report studies the global market size of Dry Eye Syndrome, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dry Eye Syndrome sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bausch & Lomb
Johnson & Johnson
Market Segment by Product Type
Over-the-counter (OTC) drugs
Market Segment by Application
Hospitals and Clinics
Key Regions split in this report: breakdown data for each region.
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Dry Eye Syndrome status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dry Eye Syndrome manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Dry Eye Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025